EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. SPY
3. MU
4. AVAV
5. NVDA
6. DLR
7. EOSE
8. TSLA
9. ABVX
10. INTC

Go back to EyeGate Pharma Reaches 75% Randomization of Patients in Pivotal Study
(NASDAQ: EYEG) Delayed: 35.34 --0 (-0%)
Previous Close $35.34    52 Week High $5.09 
Open $35.34    52 Week Low $1.11 
Day High $35.34    P/E N/A 
Day Low $35.34    EPS $0.00 
Volume 10